144 related articles for article (PubMed ID: 31170723)
1. Hepatic Encephalopathy Aggravated by Systemic Inflammation.
Manzhalii E; Virchenko O; Falalyeyeva T; Moiseienko V; Nykula T; Kondratiuk V; Savchuk O; Beregova T; Stremmel W
Dig Dis; 2019; 37(6):509-517. PubMed ID: 31170723
[TBL] [Abstract][Full Text] [Related]
2. In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy.
Wunsch E; Koziarska D; Milkiewicz M; Naprawa G; Nowacki P; Hartleb M; Milkiewicz P
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1402-7. PubMed ID: 24025977
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
[TBL] [Abstract][Full Text] [Related]
4. Microglia activation in hepatic encephalopathy in rats and humans.
Zemtsova I; Görg B; Keitel V; Bidmon HJ; Schrör K; Häussinger D
Hepatology; 2011 Jul; 54(1):204-15. PubMed ID: 21452284
[TBL] [Abstract][Full Text] [Related]
5. Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy.
Mani AR; Montagnese S; Jackson CD; Jenkins CW; Head IM; Stephens RC; Moore KP; Morgan MY
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G330-8. PubMed ID: 19023029
[TBL] [Abstract][Full Text] [Related]
6. The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor α?
Goral V; Atayan Y; Kaplan A
Hepatogastroenterology; 2011; 58(107-108):943-8. PubMed ID: 21830421
[TBL] [Abstract][Full Text] [Related]
7. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
[TBL] [Abstract][Full Text] [Related]
8. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.
Luo M; Guo JY; Cao WK
World J Gastroenterol; 2015 Nov; 21(41):11815-24. PubMed ID: 26557005
[TBL] [Abstract][Full Text] [Related]
9. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
10. Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis.
Luo M; Li L; Yang EN; Dai CY; Liang SR; Cao WK
Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):384-90. PubMed ID: 23084463
[TBL] [Abstract][Full Text] [Related]
11. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and hepatic encephalopathy.
Coltart I; Tranah TH; Shawcross DL
Arch Biochem Biophys; 2013 Aug; 536(2):189-96. PubMed ID: 23583306
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.
Shawcross DL; Davies NA; Williams R; Jalan R
J Hepatol; 2004 Feb; 40(2):247-54. PubMed ID: 14739095
[TBL] [Abstract][Full Text] [Related]
14. Animal models in the study of episodic hepatic encephalopathy in cirrhosis.
Jover R; Madaria E; Felipo V; Rodrigo R; Candela A; Compañ A
Metab Brain Dis; 2005 Dec; 20(4):399-408. PubMed ID: 16382350
[TBL] [Abstract][Full Text] [Related]
15. Ammonia Attenuates LPS-Induced Upregulation of Pro-Inflammatory Cytokine mRNA in Co-Cultured Astrocytes and Microglia.
Karababa A; Groos-Sahr K; Albrecht U; Keitel V; Shafigullina A; Görg B; Häussinger D
Neurochem Res; 2017 Mar; 42(3):737-749. PubMed ID: 27655254
[TBL] [Abstract][Full Text] [Related]
16. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.
Shawcross DL; Sharifi Y; Canavan JB; Yeoman AD; Abeles RD; Taylor NJ; Auzinger G; Bernal W; Wendon JA
J Hepatol; 2011 Apr; 54(4):640-9. PubMed ID: 21163546
[TBL] [Abstract][Full Text] [Related]
17. Elevation of Autoantibodies to Cerebral Proteins in Hepatic Encephalopathy: Another Pathogenic Factor?
Manzhalii EG; Falalyeyeva TM; Moyseyenko VO; Weiskirchen R; Stremmel W
Dig Dis; 2022; 40(2):232-238. PubMed ID: 33839722
[TBL] [Abstract][Full Text] [Related]
18. Ammonia levels and the severity of hepatic encephalopathy.
Qureshi MO; Khokhar N; Shafqat F
J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
[TBL] [Abstract][Full Text] [Related]
19. Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis.
Kalaitzakis E; Josefsson A; Castedal M; Henfridsson P; Bengtsson M; Andersson B; Björnsson E
Scand J Gastroenterol; 2013 May; 48(5):577-84. PubMed ID: 23452072
[TBL] [Abstract][Full Text] [Related]
20. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis.
Shawcross DL; Shabbir SS; Taylor NJ; Hughes RD
Hepatology; 2010 Mar; 51(3):1062-9. PubMed ID: 19890967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
